USA flag logo/image

An Official Website of the United States Government

Rare Variant Detection Using Next Genration Sequencing Technology

Award Information

Agency:
Department of Homeland Security
Branch:
N/A
Award ID:
94751
Program Year/Program:
2011 / SBIR
Agency Tracking Number:
1014004
Solicitation Year:
2010
Solicitation Topic Code:
H-SB010.1-002
Solicitation Number:
N/A
Small Business Information
Eureka Genomics
750 ALFRED NOBEL DR STE 108 Hercules, CA 94547-1837
View profile »
Woman-Owned: Yes
Minority-Owned: No
HUBZone-Owned: Yes
 
Phase 2
Fiscal Year: 2011
Title: Rare Variant Detection Using Next Genration Sequencing Technology
Agency: DHS
Contract: D11PC20117
Award Amount: $750,000.00
 

Abstract:

The long-term objective is to develop a rare variant (SNPs) detection pipeline, based on high throughput sequencing (HTS) and advanced bioinformatics, with the goal of detecting mutations present in ratio as low as 1:1000. To achieve this goal, we propose to: (1) Develop statistical and computational approaches to evaluate the effects of sequencing platform, target genome, and mapping algorithm on the accuracy of the rare variant detection. (2) Implement and deliver rare variant detection pipeline. (3) Experimentally validate the implemented rare variant detection pipeline, culminating a full scale B. anthracis case study. (4) Develop a software application to automatically acquire defined in task 1 statistical characteristics of errors associated with instruments, platforms, library preparation protocols, and sequencing chemistry, which can affect the overall accuracy of the rare variant detection. Rare variant detection is important for prosecution of bioterrorism attacks or attempts. While, the commercial opportunity of the forensic application is unknown, the commercial applications in clinical diagnostics associated with the detection of drug resistant variants such as diagnostic test to identify the presence of multi- or extensively- drug resistant tuberculosis present in less than 1 percent of the sample are significant.

Principal Investigator:

Viacheslav Fofanov
(713) 357-9587
viacheslav@eurekagenomics.com

Business Contact:

Didier Perez
(415) 269-0666
didier@eurekagenomics.com
Small Business Information at Submission:

Eureka Genomics
750 Alfred Nobel Drive #108 Hercules, CA 94547-1387

EIN/Tax ID: 261320502
DUNS: N/A
Number of Employees:
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No